Rediff.com
|
Sun Pharma, the largest Indian pharma company by value, is set to strengthen its presence in the US skincare market. Last week, Sun’s Israeli subsidiary, Taro Pharma, received the US Food and Drug Administration’s approval for its New Drug Application to launch Topicort Topical Spray for the treatment of psoriasis. Topicort (desoximetasone) is a corticosteroid indicated for the treatment of plaque psoriasis in patients of over 18 years of age. The corticosteroid spray market is ... Rediff.com, 1 month ago
|